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ABSTRACT
 A magnetic particles-based chemiluminescence immunoassay was investigated for 
progesterone detection by using luminometer. In this work, progesterone was determined based 
on the competitive binding between progesterone in the sample and progesterone-horseradish 
peroxidase (HRP) conjugate for a constant amount of  rabbit anti-progesterone. Initially, anti-
rabbit IgG coated magnetic particles conjugated with primary progesterone antibody were 
bound to progesterone in the samples. Then, the amount of  progesterone was quantified 
by reacting with the residual unoccupied antibody sites with HRP-progesterone, followed by 
HRP substrate (luminol, H2O2, and p-iodophenol (PIP)) and finally detection of  the generated 
chemiluminescence by a luminometer. The intensity of  the emitting light was proportional to 
the amount of  enzyme present (HRP-progesterone) and was inversely related to the amount 
of  unlabeled progesterone in the sample. The optimum conditions for determination of  
progesterone were obtained at 0.15 µg L-1 magnetic particles, 5.0x10-4 mol L-1 luminol, 5.0x10-3 
mol L-1 H2O2, 1.0x10
-3 mol L-1 PIP, and phosphate buffer saline buffer pH 9. The optimal 
dilutions of  both anti-progesterone antibody and HRP-progesterone conjugate were 1:1000. 
The linear relationship between chemiluminescence intensity (RLU) and various concentrations 
of  progesterone was over the concentration range of  0.5-50.0 µg L-1. This proposed method 
had been successfully applied to the evaluation of  progesterone in human sera.
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1. INTRODUCTION
Progesterone is a natural steroid hormone 
involved in the maintenance of  the female 
reproductive system. Progesterone remains 
relative constant throughout the follicular phase 
of  the menstrual cycle [1-3]. The concentration 
then increases rapidly following ovulation and 
 Chiang Mai J. Sci. 2017; 44(1)216
remains elevated for 4-6 days and decreases 
to the initial level 24 hours before the onset 
of  menstruation. In pregnancy, placental 
progesterone production rises steadily to level 
of  10 to 20 times those of  the luteal phase 
peak. Progesterone measurements are thus 
performed to determine ovulation as well as to 
characterize luteal phase defects. Monitoring of  
progesterone therapy and early stage pregnancy 
evaluations comprise the remaining uses of  
progesterone assays. 
Current methods for the quantification 
of  progesterone can be mainly divided into 
two categories: chromatographic methods 
and immunoassay methods. Chromatographic 
methods [4,5], as the reference methods for 
the measurement of  progesterone in human 
serum, have numerous predominant advantages 
of  high accuracy, selective, reproducibility and 
sensitivity. However, chromatographic methods 
have some disadvantages such as the requirement 
of  expensive instrument, intensive labour and 
complicated pretreatment of  sample. Therefore, 
the chromatographic methods could not meet 
the requirements of  clinical measurement such 
as rapidity, convenience, low cost and high 
throughput. In contrast, immunoassay methods 
are specific, easy to use and cost-effective and have 
been widely used for the clinical determination 
of  progesterone. Radioimmunoassay (RIA) 
[6,7], enzyme linked immunoabsorbent assay 
(ELISA) [8,9], time resolved fluoroimmunoassay 
(TRFIA) [10] and fluoroimmunoassay (FIA) 
[11] have also been reported for the evaluation 
of  progesterone in human serum. RIA has the 
drawbacks of  environmental contamination, 
short useful-life of  reagent and tardiness of  
determination with the use of  radioisotopes, 
which restrict its further application. The 
sensitivities of  ELISA and FIA are limited and 
they cannot be used for the measurement of  
low concentration of  progesterone in serum. 
The chemiluminescence enzyme immunoassay 
(CLEIA) overcomes the disadvantages of  the 
forementioned immunoassay methods and is 
automated completely abroad. CLEIA, which 
integrates the advantages of  immunoassay and 
chemiluminescence determination such as 
high specificity and throughput, rapidity (does 
not require long incubations), convenience in 
operation and relatively simple and inexpensive 
instrumentation, is a type of  clinical diagnostic 
technique, which is currently applied worldwide.
Magnetic particles (MPs) are typically made 
of  a magnetic iron oxide core surrounded by a 
non-magnetic polymer that can be functionalized 
with chemically functional groups, such as, 
-CONH2 and -COOH, or biomolecules of  
interest [12]. Inconsequence, MPs are usually 
used as solid supports for immunoassay reactions. 
Their features have many advantages because 
MPs have potentially large binding surface area 
per volume and hence, a large number of  analyte 
molecules are bound within a small volume, 
allowing for sensitive detection [13]. Moreover, 
MPs-based technique eliminates the need for 
sample pretreatment by centrifugation or 
filtration, therefore, shortening the time needed. 
Combining MPs with immunoassay provide 
a much faster and easier than conventional 
immunoassay because, in such a homogenous 
system, the mass-transfer distance of  analytes 
(Antigen; Ag) to the immobilized antibody 
(Ab) on the MPs is significantly decreased. In 
addition, the molecules, which are immobilized 
on MPs, can be easily and quickly separated or 
dispersed in solution by an external magnetic 
field.
In this paper, the anti-rabbit IgG is 
immobilized on carboxylic acid magnetic 
particles. After immobilization, the competitive 
binding between progesterone in the sample 
and progesterone-HRP conjugate for a constant 
amount of  rabbit anti-progesterone has been 
taken. Next, a solution of  chemiluminescence 
substrate (luminol, H2O2, PIP) is then added and 
the intensity of  the emitted light is proportional 
to the amount of  enzyme present and is inversely 
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related to the amount of  progesterone in the 
sample, was detected.
2. MATERIALS AND METHODS
2.1 Apparatus 
A chemiluminescence microplate reader 
(The POLARstar OPTIMA multi-mode micro-
plate reader; BMG LABTECH, Germany) with 
white opaque 96-well micro-plate (PerkinElmer, 
USA) that could be placed into the luminometer 
was used for the magnetic particles-based 
chemiluminescence detection. The NdFeB 
magnet of  5 mm length and 2 mm diameter 
(Swindon, UK) was used for the magnetic 
separation. A vortex mixer was used to shake 
the solution after adding the washing solution. 
2.2 Chemicals
Progesterone and progesterone-horseradish 
peroxidase (HRP) conjugate (labeled-progesterone), 
were provided by the ELISA kit (Progesterone 
ELISA kit, cat # 9025-16, Calabasas, California). 
Anti-progesterone IgG (immunoglobulin G) 
from rabbit (Ab) was purchased from Abcam, 
England. The Ab was immobilized on the surface 
of  super-paramgnetic particles (2.8 µm diameter, 
carboxylic acid active groups on the surface, 
Dynabeads®, Norway), using the following reagent 
1-ethyl-3-(3-dimethylminopropyl)-carbodiimide 
hydrochloride (EDC) and N-hydroxysuccinimide 
(NHS), all from Fluka, Switzerland. The coupling 
buffer for surface activation of  –COOH groups 
was a 2-(N-Morpholino) ethanesulfonic acid, 
pH 5 (MES, Sigma-Aldrich). Tris HCl (Sigma-
Aldrich) pH 7.4 was used for eliminate the risk 
of  unspecific binding.
The HRP substrate mixture (luminol, 
p-iodophenol (PIP) and hydrogen peroxide 
(H2O2), all from Fluka, Switzerland) was 
prepared by dissolution in 10 mM phosphate 
buffer saline, pH 7.4 (PBS, Sigma-Aldrich). 
The human serum samples were collected 
from local Hospitals and stored at -20 oC until 
required without any pretreatment.
2.3 Immobilization of  Antibody (Ab) on 
Magnetic Particles
The anti-rabbit IgG (Ab) was immobilized 
on carboxylic magnetic particles (Figure 1), 
according to the specific protocol provide by 
invitrogenÒ[M 270]. In the first step, 100 mL 
suspension of  magnetic particles, placed in 
an Eppendrof  vial, were separated from the 
solution using a permanent magnet (Swindon, 
UK). The supernatant solution was removed, 
and magnetic particles were washed by re-
suspension in 100 mL solution of  25 mmol 
L-1 MES buffer (pH 5), following magnetic 
separation and removal of  the solution. Then, 
the –COOH groups grafted on the particles 
surface were activated by adding 50 mL of  50 
mg mL-1 1-ethyl-3-(3-dimethylminopropyl)-
carbodiimide hydrochloride (EDC) and 50 mL 
of  50 mg mL-1 N-hydroxysuccinimide (NHS) 
in cold MES buffer. Further, the Eppendrof  
content was vortexed for 30 second, and then 
incubated for 30 minutes at room temperature 
under gentle mixing. The excess of  reagents 
was eliminated and the magnetic particles were 
washed by magnetic separation in/from 100 
mL solution of  25 mmol L-1 MES buffer (pH 
5). The activated magnetic particles were then 
suspension in 60 mL of  Ab solution (1 mg mL-1 
protein dissolved in 10 mmol L-1 PBS (pH 7.4)), 
and the coupling reaction was performed at 
room temperature (25 oC), under gentle stirring 
for 60 minutes. Finally, the resulting magnetic 
particles was re-suspended in 100 mL 0.05 mol 
L-1 Tris HCl pH 7.4 for 15 minutes to eliminate 
the risk of  unspecific binding, and then washed 
five times with 100 mL of  10 mmol L-1 PBS 
Figure 1. Immobilization of  antibody (Ab) 
on carboxylic magnetic particles.
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solution. The anti-rabbit IgG-coated magnetic 
particles were further stored as suspension in 
10 mmol L-1 PBS at 4 oC.
2.4 The Method for Progesterone 
Determination Using Luminometer 
The progesterone CLEIA is based on 
the principle of  competitive of  progesterone 
present in the sample and progesterone-HRP 
conjugate (labeled-progesterone) binding to 
a limited number (constant amount) of  anti-
progesterone immobilized on anti-rabbit IgG 
magnetic particles (Figure 2). In the incubation, 
anti-rabbit IgG-coated magnetic particles 
were incubated with 50 mL anti-progesterone, 
25 mL progesterone standards/samples and 
100 mL progesterone-HRP conjugate (labeled-
progesterone) at room temperature (18-25 OC) for 
at least 30 minutes with slow tilt rotation. After 
competition has reached equilibrium, unbound 
labeled-progesterone was eliminated by washing, 
and the chemiluminescence substrate (luminol 
solution containing H2O2 and p-iodophenol) 
was then added to give 3-aminophthalate and 
chemiluminescence emission was produced 
and detected by using Luminometer. The 
intensity of  the emitting light (Relative Light 
Units; RLU) was proportional to the amount 
of  enzyme present and was inversely related 
to the amount of  progesterone in the sample 
(Figure 3). 
3. RESULTS AND DISCUSSION
3.1 Effect of  Concentration of  Magnetic 
Particles
The amount of  MPs was relative to the 
amount of  anti-rabbit IgG; more antibodies 
reacted with more antigens, thereby leading to 
enhanced sensitivity. However, a large amount 
of  the MPs caused particle aggregation. 
Therefore, effect of  the amount of  MPs on 
the chemiluminescence intensity was studied 
the greatest to obtain sensitivity. The effect 
of  concentration of  magnetic particles on 
chemiluminescence intensity was investigated 
in the range of  0.015-0.15 mg mL-1, the results 
obtained were shown in Figure 4A. It was 
found that, an increase in magnetic particles 
concentrations leads to improvement in assay 
sensitivity. Thus, 0.15 mg mL-1, corresponding 
to 1x107 particles, was chosen as the optimum 
concentration of  magnetic particles with 
reasonable cost-effective.
3.2 Effect of  Dilution of  Anti-Progesterone 
The effect of  anti-progesterone antibody 
dilution was investigated in the range of  1:5000 
to 1:20, the results obtained were shown in 
Figure 4B. The chemiluminescence intensity 
(Relative Light Units; RLU) decreased with 
increasing the dilution of  anti-progesterone 
antibody. Considering the anti-progesterone 
cost in the use, the dilution ration 1:1000 was 
chosen in all subsequent with reasonable of  a 
compromise between high sensitivity and the 
Figure 2. Competitive assay.
Figure 3. Magnetic particles-based procedures 
for progesterone determination using a 
luminometer.
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Figure 4. Optimization of  reagent concentrations for progesterone determination by using 
MPs-based CLEIA method: CL signal (RLU) as function of: (A) magnetic particles concentration; 
(B) anti-progesterone dilution; (C) progesterone-HRP concentration; (D) luminol concentration; 
(E) PIP concentration; (F) H2O2 concentration; and (G) pH. 
cost assay. To increase sensitivity, 1:100 diluted 
of  anti-progesterone was being used instead.
3.3 Effect of  Progesterone-HRP Dilution
This study was carried out at various 
progesterone-HRP dilutions between 50000 
to 500 fold dilutions, the results obtained 
were shown in Figure 4C. It was found that, 
the RLU increased with increasing dilution 
of  progesterone-HRP from 50000 diluted 
to 1000 folds and then, slightly decreased at 
500 folds due to limited number (constant 
amount) of  anti-progesterone immobilized on 
magnetic particles. Hence, 1000 fold dilutions 
progesterone-HRP was chosen for further 
progesterone determination.
3.4 Effect of  Luminol Concentration
The effect of  luminol concentration on the 
RLU was studied by varying the concentration 
of  luminol from 5x10-5 - 1x10-2 mol L-1, the 
results obtained were shown in Figure 4D. It 
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was found that, the RLU increased rapidly up 
to 5.0x10-4 mol L-1 luminol, and then, further 
increment of  luminol concentration, the RLU 
decreased rather rapidly and reaching its minimum 
value as soon as the luminol concentration 
increased to 1x10-2 mol L-1. Hence, the 5x10-4 
mol L-1 luminol was chosen as optimum luminol 
concentration for the proposed method, which 
was used throughout the experiments. 
3.5 Effect of  PIP Concentration 
Light emission from luminol-H2O2-
peroxidase system can be greatly enhanced by 
the addition of  PIP. The underlying mechanism 
of  this enhanced chemiluminescence is not 
completely understood. The most probable 
explanation is that these chemiluminescence 
enhancers can accelerate one or more of  the 
oxidation step to generate luminol radicals 
during the complex reaction pathway of  the 
enzymatic oxidation of  luminol. This study 
was carried out at various PIP concentrations 
between 1x10-4 - 1x10-2 mol L-1. As can be 
seen in Figure 4E, the maximum RLU was 
obtained with 1x10-3 mol L-1 PIP, above this 
concentration the RLU decrease. Therefore, 
the 1x10-3 mol L-1 PIP was selected as optimum 
condition for further work.
3.6 Effect of  H2O2 Concentration 
The effect of  hydrogen peroxide concentration 
was investigated over the range 1x10-4 - 1x10-2 
mol L-1, the results obtained were shown in 
Figure 4F. It can be seen that RLU increased 
with increasing H2O2 concentration from 1x10
-4 
-5x10-3 mol L-1, and then decreased as soon 
as the H2O2 concentration was beyond 5x10
-3 
mol L-1. Therefore, the 5x10-3 mol L-1 H2O2 
was regarded as the optimum concentration 
for the following studies.
3.7 Effect of  pH
It is well-known that the chemiluminescence 
intensity of  luminol is pH dependence. Oxidation 
of  luminol catalyzed by a peroxidase system 
is affected by the pH value of  the solution. 
Although HRP is stable in the pH range 4.2-
12.0, its activity in the soluble state is maximal 
at pH 7.0 and greatly reduced under alkaline 
conditions [14]. However, luminol CL system 
is most efficient at pHs above 9.0 [15], and 
this large difference in pH optima significantly 
limits the application possibilities of  peroxidase-
catalyzed CL. Hence, the influence of  pH values 
of  the solution was carried out at various pH 
values between pH 7.0-10.5. As can be seen 
in Figure 4G, the optimum pH (9.0-10.0) for 
luminol CL catalyzed by a peroxidase-antibody 
conjugate in solution probably reflects a 
compromise where peroxidase retains some 
activity and luminol CL is possible. When the 
pH of  luminol system exceeded 10, the HRP-
labeled antibody would denature and become 
immunologically unresponsive. Although the 
highest RLU was obtained at pH 10, however 
at pH 9.0 a high response was also obtained 
with better repeatability. Hence, this pH was 
chosen for further progesterone determination.
3.8 Analytical Characteristics
3.8.1 Calibration Curve
A calibration curve was obtained by 
measurement the RLU of  the immobilized 
magnetic particles using progesterone standard 
solutions in the range of  0 to 50 µg L-1 under the 
optimum conditions. The optimum conditions 
for determination of  progesterone were obtained 
at 0.15 µg L-1 magnetic particles, 5.0x10-4 mol 
L-1 luminol, 5.0x10-3 mol L-1 H2O2, 1.0x10
-3 
mol L-1 PIP, and phosphate buffer saline buffer 
pH 9.0. The optimal dilutions of  both anti-
progesterone antibody and HRP-progesterone 
conjugate were 1:1000. The measurement was 
made in three replicates for each standard 
solution. Calibration curve were obtained 
by plotting CL intensity (RLU) against the 
logarithm of  analyte concentration and fitted 
to the equation of  logit Y – log X, in which 
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the value of  logit Y was calculated according 
to the formula as follows:
Logit Y = ln [
Where, Y = C/C0, C0 is the CL intensity of  the 
zero calibrator, C is the CL intensity of  other 
calibrators or samples, and X is concentration 
of  progesterone. These results were shown 
in Figure 5. The calibration curve was linear 
over the range 0.5-50 µg L-1 and the linear 
regression equation of  logit y = -2.24logx + 
1.903. The linear correlative coefficient for this 
line was 0.9932. 
3.8.2 Limit of  Detection (LOD) and 
Repeatability
The detection limit was determined by 
calculating the minimum amount of  progesterone 
that could be markedly distinguished from C0 
(mean binding at C0-2SD). It was found to be 
0.33 µg L-1 progesterone. The repeatability for 
determining progesterone (10 µg L-1) were carried 
out by replicate injections (n = 11) within the 
same day was less than 17%. 
 
3.9 Determination of  Progesterone in Serum
Ten women sera were determined by both 
the proposed method and the progesterone kit 
(CLEIA). Three replicates of  all measurements 
were made. It was shown that progesterone was 
found to be in the range of  0.72-16.97 µg L-1. 
Comparative determination of  progesterone 
in serum by using the proposed method and 
the progesterone kit (CLEIA) was also carried 
out. The results obtained from the proposed 
method compared favorably with those obtained 
using progesterone kit. Statistical analysis of  
Figure 5. Relationship between progesterone concentrations and Relative Light Units (RLU) by 
plotting (A) various progesterone concentrations (µg L-1) vs. RLU and (B) the log-log plot of  (A). 
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the results by using t-test showed that there 
were no significant differences between the 
two methods at 95% confidence, demonstrating 
that the proposed method is as accurate and 
precise as the progesterone kit (CLEIA). The 
results were summarized in Table 1.
4. CONCLUSION
The magnet ic  par t ic les-based 
chemiluminescence enzyme immunoassay 
(CLEIA) procedures have been developed for 
progesterone determination, using HRP-PIP-
H2O2-luminol chemiluminescence system. The 
proposed method presented high accuracy, 
and sensitivity (LOD = 0.33 µg L-1), simplicity 
and reliability. The proposed method has been 
successfully applied to the determination of  
progesterone in human sera and showed a 
good agreement between the proposed method 
and the commercial CLEIA kit (verified by 
Student’s t-test). The proposed method seem to 
be promising as an alternative method for the 
routine assays and facilitated the development 
of  high-throughput screening and automated 
operation systems in clinical diagnosis. 
ACKNOWLEDGEMENTS
The authors would like to express their 
sincere thanks to Center of  Excellence for 
Innovation in Chemistry (PERCH-CIC) 
Department of  Chemistry and The Thailand 
Research Fund (TRF) Royal Golden Jubilee 
Project (RGJ) together with the Commission 
on Higher Education (CHE) Ministry of  
Education Thailand for their very kind financial 
supports. Specially partial support from Materials 
Science Research Center would be gratefully 
acknowledged. We also would like to express 
our sincere thanks to the Graduate School and 
the Department of  chemistry Faculty of  Science 
Chiang Mai University for their partial support.
Table 1. Comparison between results measured by the proposed method and the CLEIA kit.
Sample code
























































*Mean ± RSD of  three determinations (n= 3)
aTabulated t-value for p = 0.05 and two degrees of  freedom is 2.78.
bTabulated F-value for p = 0.05 and two degrees of  freedom is 19.
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